Diversified Healthcare Trust (DHC)’s valuation ratios: A closer look

The closing price of Diversified Healthcare Trust (NASDAQ: DHC) was $1.13 for the day, down -2.59% from the previous closing price of $1.16. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 3206544 shares were traded. DHC stock price reached its highest trading level at $1.1600 during the session, while it also had its lowest trading level at $1.0700.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



Our analysis of DHC’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 1.08.

Upgrades & Downgrades

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DHC now has a Market Capitalization of 210.92M and an Enterprise Value of 2.60B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.20 while its Price-to-Book (P/B) ratio in mrq is 0.10. Its current Enterprise Value per Revenue stands at 1.97 whereas that against EBITDA is 19.24.

Stock Price History:

Over the past 52 weeks, DHC has reached a high of $2.37, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 1.1090, while the 200-Day Moving Average is calculated to be 1.0984.

Shares Statistics:

DHC traded an average of 4.48M shares per day over the past three months and 3.63M shares per day over the past ten days. A total of 238.59M shares are outstanding, with a floating share count of 236.44M. Insiders hold about 0.10% of the company’s shares, while institutions hold 82.30% stake in the company. Shares short for DHC as of Apr 27, 2023 were 4.25M with a Short Ratio of 4.25M, compared to 10.36M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.77% and a Short% of Float of 2.00%.

Dividends & Splits

With its trailing 12-month dividend rate of 0.04, DHC has a forward annual dividend rate of 0.04. Against a Trailing Annual Dividend Yield of 3.45%, it implies a Forward Annual Dividend Yield of 3.81%. The stock’s 5-year Average Dividend Yield is 6.74.

Earnings Estimates

The firm’s stock currently is rated by 1 analysts. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.23, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.

Analysts are recommending an EPS of between -$0.86 and -$0.86 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is -$0.83, with 1 analysts recommending between -$0.83 and -$0.83.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $353.15M to a low estimate of $353.15M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $313.03M, an estimated increase of 12.80% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $358.01M, an increase of 10.90% less than the figure of $12.80% in the same quarter last year. There is a high estimate of $358.03M for the next quarter, whereas the lowest estimate is $358M.

A total of 1 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.42B, resulting in an average revenue estimate of $1.42B. In the same quarter a year ago, actual revenue was $1.28B, up 10.90% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.53B in the next fiscal year. The high estimate is $1.53B and the low estimate is $1.53B. The average revenue growth estimate for next year is up 7.70% from the average revenue estimate for this year.